Elisabeth Hertle

567 total citations
10 papers, 384 citations indexed

About

Elisabeth Hertle is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Elisabeth Hertle has authored 10 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Hematology and 3 papers in Genetics. Recurrent topics in Elisabeth Hertle's work include Complement system in diseases (6 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Elisabeth Hertle is often cited by papers focused on Complement system in diseases (6 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Elisabeth Hertle collaborates with scholars based in Netherlands, China and Guatemala. Elisabeth Hertle's co-authors include Coen D.A. Stehouwer, Marleen M. J. van Greevenbroek, Carla Kallen, Casper G. Schalkwijk, Timo Peter, Bart Groen, Wim H. M. Saris, Bart Pennings, Joan M. Senden and Luc J. C. van Loon and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Diabetologia and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Elisabeth Hertle

10 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Hertle Netherlands 9 134 87 82 66 61 10 384
Marian van Kraaij Netherlands 10 104 0.8× 30 0.3× 153 1.9× 73 1.1× 205 3.4× 20 592
Jana Potočková Czechia 12 52 0.4× 32 0.4× 126 1.5× 83 1.3× 71 1.2× 37 391
Jerome E. Stasek United States 7 68 0.5× 38 0.4× 64 0.8× 145 2.2× 122 2.0× 9 467
Martina Gaggl Austria 10 103 0.8× 21 0.2× 72 0.9× 45 0.7× 33 0.5× 39 316
Alba Carrea Italy 15 66 0.5× 49 0.6× 81 1.0× 224 3.4× 61 1.0× 30 728
Pavel Kraml Czechia 12 59 0.4× 15 0.2× 64 0.8× 65 1.0× 109 1.8× 45 387
Lorenzo Machado United States 7 59 0.4× 34 0.4× 248 3.0× 116 1.8× 164 2.7× 8 636
Mahnaz Sandoughi Iran 14 155 1.2× 15 0.2× 36 0.4× 147 2.2× 41 0.7× 41 577
T Shimokawa Japan 9 73 0.5× 17 0.2× 60 0.7× 74 1.1× 92 1.5× 14 365
Maki Kumada Japan 9 50 0.4× 27 0.3× 116 1.4× 195 3.0× 84 1.4× 18 407

Countries citing papers authored by Elisabeth Hertle

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Hertle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Hertle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Hertle more than expected).

Fields of papers citing papers by Elisabeth Hertle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Hertle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Hertle. The network helps show where Elisabeth Hertle may publish in the future.

Co-authorship network of co-authors of Elisabeth Hertle

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Hertle. A scholar is included among the top collaborators of Elisabeth Hertle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Hertle. Elisabeth Hertle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hertle, Elisabeth, Carla Kallen, Nicole Vogelzangs, et al.. (2021). C3 and alternative pathway components are associated with an adverse lipoprotein subclass profile: The CODAM study. Journal of clinical lipidology. 15(2). 311–319. 16 indexed citations
2.
Hertle, Elisabeth, et al.. (2020). Associations of dicarbonyl stress with complement activation: the CODAM study. Diabetologia. 63(5). 1032–1042. 5 indexed citations
3.
4.
Hertle, Elisabeth, Ilja C.W. Arts, Carla Kallen, et al.. (2018). Classical Pathway of Complement Activation: Longitudinal Associations of C1q and C1-INH With Cardiovascular Outcomes. Arteriosclerosis Thrombosis and Vascular Biology. 38(5). 1242–1244. 21 indexed citations
5.
Hertle, Elisabeth, et al.. (2017). Longitudinal associations of the alternative and terminal pathways of complement activation with adiposity: The CODAM study. Obesity Research & Clinical Practice. 12(3). 286–292. 15 indexed citations
6.
Hertle, Elisabeth, Ilja C.W. Arts, Carla Kallen, et al.. (2016). Distinct Longitudinal Associations of MBL, MASP-1, MASP-2, MASP-3, and MAp44 With Endothelial Dysfunction and Intima–Media Thickness. Arteriosclerosis Thrombosis and Vascular Biology. 36(6). 1278–1285. 15 indexed citations
7.
Hertle, Elisabeth, Ilja C.W. Arts, Carla Kallen, et al.. (2015). The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes. Thrombosis and Haemostasis. 115(2). 446–457. 30 indexed citations
8.
Hertle, Elisabeth, Coen D.A. Stehouwer, & Marleen M. J. van Greevenbroek. (2014). The complement system in human cardiometabolic disease. Molecular Immunology. 61(2). 135–148. 102 indexed citations
9.
Hertle, Elisabeth, Marleen M. J. van Greevenbroek, & Coen D.A. Stehouwer. (2012). Complement C3: an emerging risk factor in cardiometabolic disease. Diabetologia. 55(4). 881–884. 70 indexed citations
10.
Groen, Bart, Timo Peter, Bart Pennings, et al.. (2011). Intragastric protein administration stimulates overnight muscle protein synthesis in elderly men. American Journal of Physiology-Endocrinology and Metabolism. 302(1). E52–E60. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026